What it is
Mild cognitive impairment, called mild neurocognitive disorder in current diagnostic terms, describes a decline in memory or thinking that is real and noticeable, to the person or those close to them, and measurable on testing, but that is not yet severe enough to significantly interfere with the ability to live independently and manage daily life. It sits in the middle ground between the normal changes of ageing and the more disabling decline of dementia.
This middle position is the key to understanding it, and to why it is neither a reason for panic nor something to ignore. Mild cognitive impairment is not dementia, and it does not always lead there. Over time, some people remain stable, some even return to normal, and some go on to develop dementia. Identifying it opens a window for action.
What it can look like
Most often it shows as memory difficulty: forgetting recent conversations, appointments or events more than before, in a way that is noticeable but does not stop the person managing their own affairs. In other people it affects thinking speed, attention, language or planning rather than memory. The person can still work, drive, manage money and run their household, perhaps with a little more effort or with notes and reminders. It is this preserved independence that distinguishes it from dementia, where such tasks become genuinely difficult.
How common is it and what it can mean
Mild cognitive impairment is common in older adults. Its significance varies: research shows that, on average, people with it have a higher chance of developing dementia over the following years than those without it, but this is far from certain for any individual, and a meaningful proportion remain stable or improve. Because of this, it is best seen not as early dementia but as a signal worth taking seriously, an opportunity to look for treatable causes and to act on brain health.
What causes it and the treatable mimics
The causes are varied. In some people it reflects the earliest changes of a condition such as Alzheimer's or vascular disease; in others it has a quite different and often reversible cause. This is why assessment matters so much, because several common conditions can cause exactly this picture and can be treated: depression, which frequently affects memory and concentration, thyroid problems, vitamin deficiencies (especially vitamin B12), poor sleep including sleep apnoea, medication side effects, alcohol, and untreated high blood pressure or diabetes. Finding and treating one of these can resolve the problem entirely.
How it is diagnosed
A doctor assesses memory and thinking with the person and, helpfully, with someone who knows them well, confirms that daily independence is largely preserved, and crucially looks for the treatable causes above through history, examination and blood tests. Where appropriate, follow-up over time shows whether things are stable, improving or progressing, which is itself valuable information. The aim is to catch reversible causes, support brain health, and monitor, rather than to label someone with a frightening diagnosis they may never develop.
How it is treated and supported
There is no medicine established to treat mild cognitive impairment itself, and the memory drugs used in Alzheimer's disease are not recommended for it. What helps is twofold. First, treat any reversible cause found: lift the depression, correct the deficiency, improve the sleep, review the medicines, manage the blood pressure. Second, support brain health through the same evidence-based steps that reduce dementia risk generally: regular physical activity, staying mentally and socially engaged, managing blood pressure, diabetes and cholesterol, addressing hearing loss, not smoking, limiting alcohol, and eating well. These steps are good for the whole body, achievable without specialist services, and may lower the chance of progression. Ongoing monitoring means that if things do progress, support is already in place.
Mild cognitive impairment in the African context
Memory changes in later life are often accepted as simply normal ageing here, so mild cognitive impairment is rarely assessed, yet this is exactly the stage where action helps most. Many causes are treatable mimics, depression, thyroid problems, vitamin deficiencies, poor sleep, medication effects, and uncontrolled blood pressure or diabetes, all common and reversible, so assessment can find a problem that can actually be fixed. Where it reflects early brain change, controlling blood-pressure and other risks, staying active, and remaining socially and mentally engaged are among the best protections. Recognising it as worth checking, rather than just old age, is the useful step.
Supporting someone with mild cognitive impairment
Practical support and healthy habits matter at this stage.
- Encourage a medical check for treatable causes, since several are common and reversible.
- Support blood-pressure and diabetes control, physical activity, good sleep, and social and mental engagement, which protect the brain.
- Help with reminders and routines for memory, without taking over more than needed.
- Treat any depression or anxiety, which can both mimic and worsen memory problems.
- Keep an eye on changes over time, and seek review if difficulties grow. Our find a therapist page can help.
When to seek help
Seek assessment if you or someone close to you notices a real, persistent decline in memory or thinking that is more than you would expect, even if daily life is still manageable. Far from being alarmist, this is the ideal time to look for treatable causes and to act on brain health. Ask specifically about checking for depression, thyroid problems, vitamin B12, sleep and medication effects, since these are common, treatable, and easily missed.
Sources
- American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.).
- Petersen, R. C., et al. (2018). Practice guideline update summary: Mild cognitive impairment. Neurology, 90(3), 126-135.
- Livingston, G., et al. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet, 396(10248), 413-446.